• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 2 > Press

In the media

Page 2 > Press

In the media

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

News
31 Mar 2026

DNDi is looking for a Board Treasurer to join its Board of Directors

Chemistry World logo, C and W letters in a light grey on a black background
In the media
26 Mar 2026

Boron plays a key role in new sleeping sickness drug

Chemistry World
Title copy on white and orange background, picture of Fr Robinson on the right hand
Videos
26 Mar 2026

Manufacturing medicines for NTDs, with Dr Stephen Robinson

Scientific articles
14 Jan 2026

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The Lancet Microbe
Scientific articles
24 Mar 2026

The burden of eumycetoma in Africa: a neglected fungal disease

The Lancet Regional Health – Africa
Statements
23 Mar 2026

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

TV5Monde-logo
In the media
18 Mar 2026

RD Congo : Un nouveau traitement contre la maladie du sommeil

TV5Monde
NPR logo
News
16 Mar 2026

A new drug could be the beginning of the end for sleeping sickness

NPR
Science logo
News
16 Mar 2026

The Best Weapon Yet Against Sleeping Sickness

Science
Sci Dev Net logo
News
16 Mar 2026

Why sleeping sickness pill is raising hopes in Africa

SciDev.Net
El Periódico logo
In the media
15 Mar 2026

Tres pastillas en una dosis única, la bala de plata contra la enfermedad del sueño

El Periódico
In the media
14 Mar 2026

Africa’s one-dose cure brings sleeping sickness elimination within reach

The Independent
Nature logo
In the media
12 Mar 2026

Single-dose sleeping sickness drug set for approval

Nature
Sci Dev Net logo
In the media
12 Mar 2026

Faire des morsures de serpent une priorité de santé publique

SciDev.Net
Woman and Men in their house smiling
News
12 Mar 2026

2025 R&D programmes in review: Sleeping sickness

Woman in a field smiling
News
12 Mar 2026

2025 R&D programmes in review: Leishmaniasis

loading
Loading...
France 24 logo
In the media
27 Feb 2026

La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement

France 24
Le Monde logo
In the media
27 Feb 2026

Maladie du sommeil : l’autorisation européenne d’un nouveau traitement laisse entrevoir une élimination de la maladie d’ici à 2030

Le Monde
Bloomberg logo
In the media
27 Feb 2026

New pill has potential to eliminate deadly sleeping sickness

Bloomberg
AP logo
In the media
27 Feb 2026

New sleeping sickness pill gets nod, paving the way for use in Africa

Associated Press
KBC logo
In the media
27 Feb 2026

Breakthrough single-dose treatment for sleeping sickness gets EU nod

KBC
In the media
27 Feb 2026

Single-dose sleeping sickness pill clears major EU regulatory milestone

Capital FM
Citizen TV logo
In the media
27 Feb 2026

EMA gives positive opinion for single-dose sleeping sickness medication

Citizen Digital
Fierce Pharma logo, red copy on white background
In the media
27 Feb 2026

After CHMP nod, Moderna CEO applauds EU’s ‘rigorous scientific review’

Fierce Pharma
China Philantrophist magazine logo, cp letters in dark red and chinese characters in black
In the media
26 Feb 2026

被忽视疾病的希望

China Philanthropy Magazine
In the media
17 Feb 2026

Still no specific treatment for dengue despite global risk

The Sun
France 24 logo
In the media
8 Feb 2026

Neglected killer: Kala-azar disease surges in Kenya

France 24
The Lancet Infectious Diseases logo
In the media
4 Feb 2026

Leishmaniasis: a story of two continents

The Lancet
In the media
1 Feb 2026

Maladies négligées : un modèle qui tient ses promesses

Pharmaceutiques
The Hindu logo
In the media
31 Jan 2026

Kala-azar in India: Treading the last mile towards elimination

The Hindu
In the media
30 Jan 2026

顧みられない患者に治療を アフリカ睡眠病の新薬開発し野口英世賞

Asahi
Nature India Logo
In the media
30 Jan 2026

Why India still carries the heaviest burden of neglected tropical diseases

Nature India
1 2 … 129 ›

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Twitter Facebook Instagram Youtube Linkedin
EN ESPAÑOL
EM PORTUGUÊS
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license